Shanghai has focused on developing the biopharmaceutical industry for 30 years and its industrial output value has increased from 5 billion yuan to nearly 200 billion yuan.

"This year marks the 30th anniversary of Shanghai's focus on developing the biopharmaceutical industry. Over the past 30 years, Shanghai Biomedicine has grown from an industry with an industrial output value of less than 5 billion yuan (RMB, the same below) to an industrial output value of nearly 200 billion yuan and an industry scale of nearly 900 billion yuan of emerging industries." Wu Jincheng, director of the Shanghai Economic and Information Commission, said on the 7th.

He said that Shanghai is the birthplace of China’s modern pharmaceutical industry and the innovation highland of China’s biopharmaceutical industry. In 1993, Shanghai took the lead in classifying the modern biological and pharmaceutical industries as high-tech industries that are key to development. After 30 years of development, Shanghai has accelerated the formation of a world-class biopharmaceutical industry cluster like a "tropical rainforest".

"Since 2019, Shanghai has been approved for a total of 17 Class 1 innovative drugs, accounting for about 1/4 of the country. More than 80% of the top 20 international pharmaceutical and device companies have set up their Chinese headquarters or R&D and production headquarters in Shanghai ." He introduced.

The 2023 Shanghai International Biopharmaceutical Industry Week will be held this month. This year, the industry week will hold a concurrent event overseas for the first time - the "International Science and Practice Conference and Central Asia-China High-end Biopharmaceutical Exhibition" will be held in Kyrgyzstan. , share relevant results with overseas counterparts, and help Chinese companies set up locations and cooperate in Central Asia.

"Through 30 years of exploration and practice, we have realized that the development of the biomedical industry mainly relies on development factors such as innovation, clinical practice, finance, and talents." Wu Jincheng said. For example, the number of employees in Shanghai's biopharmaceutical industry reaches 280,000.

Shanghai will “increase” the development of the biopharmaceutical industry. Liu Ping, deputy director of the Shanghai Municipal Economic and Information Technology Commission, said that currently, Shanghai has gathered more than 1,400 biomedical companies and more than 100 professional service platforms, and plans to build a biomedical standard factory with a total scale of nearly 5 million square meters.